Tag Archive | "medivation"

Medivation has signed a exclusive pharma licensing deal with CureTech

Tags: , , , ,

Medivation has signed pharma licensing deal for exclusive worldwide rights to CureTech's late-stage clinical molecule pidilizumab (CT-011), an immune modulatory anti-PD-1 monoclonal antibody. Read the full story

Partnering Agreements with Medivation

Tags: ,

The Partnering Agreements with Medivation report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. Read the full story

Medivation: Biopharmaceutical partnering activity 2009 -2014

Tags: ,

Medivation, a top big biotech company headquartered in the USA, is focused on development of therapies to treat serious diseases. This article throws light on the partnering activity of this successful biopharmaceutical company since 2009. Read the full story

Medivation – Acquiring early…developing….then partnering

Tags: , ,

Medivation is a biopharmaceutical company developing novel therapies for serious diseases with limited medical solutions. Read the full story

Medivation: Company profile

Tags: ,

Medivation, a top big biotech company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story